Astrazeneca Share News (AZN)

TOP NEWS: AstraZeneca sells Ohio manufacturing site

(Alliance News) - AstraZeneca PLC on Wednesday announced the sale of its West Chester manufacturing site in the US state of Ohio to National Resilience Inc.

AstraZeneca sells US manufacturing site

(Sharecast News) - AstraZeneca has agreed to sell a US manufacturing site to National Resilience.

TOP NEWS: AstraZeneca to buy Neogene for cancer treatment

(Alliance News) - AstraZeneca PLC said it agreed to buy Neogene Therapeutics Inc for the treatment of cancer, as also noted by healthcare company Syncona Ltd on Tuesday.

LONDON MARKET OPEN: Stocks up as protests in China deterred by police

(Alliance News) - The FSTE 100 opened in the green on Tuesday as investors were reassured that civil unrest in China would be short lived amid unyielding action by the authorities.

AstraZeneca boosts cancer portfolio with $320 mln Neogene deal

Nov 29 (Reuters) - AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments.

LONDON BRIEFING: easyJet boasts "record bounce back" as loss narrows

(Alliance News) - Stocks in London were set to open slightly higher on Tuesday as unrest in the world's second largest economy continued.

AstraZeneca to buy biotech Neogene for up to $320m

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy biotechnology group Neogene for up to $320m, as it looks to accelerate its ambition in oncology cell therapy.

C4X Discovery shares up as signs USD400 million deal with AstraZeneca

(Alliance News) - C4X Discovery Holdings PLC on Monday said it signed an exclusive worldwide licensing agreement with AstraZeneca PLC for its NRF2 Activator programme.

FTSE 100 eases as China COVID surge knocks energy, mining stocks

Oil, mining stocks lead losses on FTSE 100

*

Macron hosts European CEOs to counter US move temptation

PARIS, Nov 21 (Reuters) - French President Emmanuel Macron on Monday will host a dinner with a number of European chief executives to convince them not to move production to the United States, where lower energy prices and the Inflation Reduction Act is proving a lure.

Big Pharma may have to reveal government deals in WHO's draft pandemic rules

LONDON/GENEVA, Nov 17 (Reuters) - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord reviewed by Reuters.

Big Pharma may have to reveal government deals in WHO's draft pandemic rules

LONDON/GENEVA, Nov 17 (Reuters) - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord reviewed by Reuters.

Big Pharma may have to reveal government deals in WHO's draft pandemic rules

LONDON, Nov 17 (Reuters) - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future pandemics, under new rules being drawn up by the World Health Organization and reviewed by Reuters.

Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective

LONDON, Nov 16 (Reuters) - Britain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co's's antiviral pill for high-risk patients, citing cost-effectiveness concerns.

Big pharma not doing enough to improve drug access - analysis

LONDON, Nov 15 (Reuters) - Since the pandemic emerged, more top drugmakers have made progress in improving access to medicines in the developing world, but those gains are largely limited to middle-income countries leaving the poorest behind, an analysis has found.